GB0916334D0 - Inhibition of tendon adhesions - Google Patents

Inhibition of tendon adhesions

Info

Publication number
GB0916334D0
GB0916334D0 GBGB0916334.6A GB0916334A GB0916334D0 GB 0916334 D0 GB0916334 D0 GB 0916334D0 GB 0916334 A GB0916334 A GB 0916334A GB 0916334 D0 GB0916334 D0 GB 0916334D0
Authority
GB
United Kingdom
Prior art keywords
inhibition
tendon adhesions
adhesions
tendon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0916334.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renovo Ltd
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Priority to GBGB0916334.6A priority Critical patent/GB0916334D0/en
Publication of GB0916334D0 publication Critical patent/GB0916334D0/en
Priority to PCT/GB2010/051555 priority patent/WO2011033306A1/en
Priority to TW099131771A priority patent/TW201114429A/en
Priority to ARP100103400A priority patent/AR078393A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0916334.6A 2009-09-17 2009-09-17 Inhibition of tendon adhesions Ceased GB0916334D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0916334.6A GB0916334D0 (en) 2009-09-17 2009-09-17 Inhibition of tendon adhesions
PCT/GB2010/051555 WO2011033306A1 (en) 2009-09-17 2010-09-16 Inhibition of tendon adhesions
TW099131771A TW201114429A (en) 2009-09-17 2010-09-17 Inhibition of tendon adhesions
ARP100103400A AR078393A1 (en) 2009-09-17 2010-09-17 INHIBITION OF THE FORMATION OF ADHESIONS IN THE TENDONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0916334.6A GB0916334D0 (en) 2009-09-17 2009-09-17 Inhibition of tendon adhesions

Publications (1)

Publication Number Publication Date
GB0916334D0 true GB0916334D0 (en) 2009-10-28

Family

ID=41277878

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0916334.6A Ceased GB0916334D0 (en) 2009-09-17 2009-09-17 Inhibition of tendon adhesions

Country Status (4)

Country Link
AR (1) AR078393A1 (en)
GB (1) GB0916334D0 (en)
TW (1) TW201114429A (en)
WO (1) WO2011033306A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10634741B2 (en) 2009-12-04 2020-04-28 Endomagnetics Ltd. Magnetic probe apparatus
US9427186B2 (en) 2009-12-04 2016-08-30 Endomagnetics Ltd. Magnetic probe apparatus
JP6351639B2 (en) 2013-03-11 2018-07-04 エンドマグネティクス リミテッド Hypotonic solution for lymph node detection
US9239314B2 (en) 2013-03-13 2016-01-19 Endomagnetics Ltd. Magnetic detector
US9234877B2 (en) 2013-03-13 2016-01-12 Endomagnetics Ltd. Magnetic detector
EP3782575A1 (en) 2015-06-04 2021-02-24 Endomagnetics Ltd. Marker materials and forms for magnetic marker localization (mml)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9205800D0 (en) * 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders
GB9516012D0 (en) 1995-08-04 1995-10-04 Univ Manchester Pharmaceutical composition
US6093388A (en) * 1996-08-12 2000-07-25 Btg International Limited Mannose-6-phosphate composition and its use in treating fibrotic disorders

Also Published As

Publication number Publication date
TW201114429A (en) 2011-05-01
WO2011033306A1 (en) 2011-03-24
AR078393A1 (en) 2011-11-02

Similar Documents

Publication Publication Date Title
ZA201700326B (en) Inhibitors of beta-secretase
IL202366A0 (en) RNAi INHIBITION OF ALPHA-ENAC EXPRESSION
DOP2012000114A (en) BROMODOMINIUM INHIBITOR OF BENZODIAZEPINA
EP2440054A4 (en) Pyridil-triazine inhibitors of hedgehog signaling
SG2014005318A (en) Compositions and methods for inhibition of the jak pathway
WO2011047384A9 (en) Methods of inhibiting ire1
EP2282755A4 (en) Inhibition of angiogenesis
EP2438246A4 (en) Aspects of construction
GB0915515D0 (en) Treatment of vasculoproliferative conditions
IL212119A0 (en) Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
EP2507373A4 (en) Compositions and methods for inhibition of vegf
GB0916334D0 (en) Inhibition of tendon adhesions
GB0911890D0 (en) Alpha-bodies for HIV entry inhibition
PL396134A1 (en) Inhibition of the formation of scale in acidic conditions
SI2411376T1 (en) Inhibitors of nf-kb
GB0903740D0 (en) Mrthod for reducing the viscosity of biosolids
PT2504016T (en) Inhibition of pancreatic lipase
ZA200908301B (en) Rnai inhibition of alpha-enac expression
GB0916333D0 (en) Improvement of tendon repair
AU2009905332A0 (en) Inhibition of tolerance
GB0715788D0 (en) Inhibition of corrosion
GB0914739D0 (en) Enzyme inhibition
GB0914742D0 (en) Enzyme inhibition
GB0908609D0 (en) New use of isoQC inhibitors
GB0915895D0 (en) Method of cleansing

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)